- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Swiss Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Results
23
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
23 companies
Roche Holding
Market Cap: CHF 273.4b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 319.50
7D
0.5%
1Y
29.5%
Novartis
Market Cap: CHF 206.7b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 107.74
7D
1.7%
1Y
23.8%
Cosmo Pharmaceuticals
Market Cap: CHF 1.6b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 101.00
7D
5.4%
1Y
70.9%
Tecan Group
Market Cap: CHF 1.6b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 126.90
7D
-1.4%
1Y
-35.7%
MindMaze Therapeutics Holding
Market Cap: CHF 421.9m
NeuroX Group SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
MMTX
CHF 2.77
7D
n/a
1Y
n/a
Sandoz Group
Market Cap: CHF 25.0b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 58.08
7D
-1.6%
1Y
56.8%
Galderma Group
Market Cap: CHF 39.1b
Operates as a dermatology company worldwide.
GALD
CHF 164.80
7D
1.0%
1Y
71.3%
Siegfried Holding
Market Cap: CHF 3.3b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 74.60
7D
2.8%
1Y
-23.4%
Newron Pharmaceuticals
Market Cap: CHF 445.1m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 22.30
7D
15.4%
1Y
175.0%
Lonza Group
Market Cap: CHF 37.2b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 530.20
7D
1.1%
1Y
0.4%
Santhera Pharmaceuticals Holding
Market Cap: CHF 162.0m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 12.12
7D
-1.9%
1Y
21.4%
Xlife Sciences
Market Cap: CHF 122.3m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 21.20
7D
-16.5%
1Y
-18.5%
Curatis Holding
Market Cap: CHF 59.7m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 11.85
7D
-2.1%
1Y
-6.0%
SKAN Group
Market Cap: CHF 1.1b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 50.10
7D
2.5%
1Y
-33.1%
Bachem Holding
Market Cap: CHF 4.2b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 56.00
7D
6.5%
1Y
-8.4%
Kuros Biosciences
Market Cap: CHF 1.1b
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 27.72
7D
-8.0%
1Y
33.6%
Molecular Partners
Market Cap: CHF 125.7m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.36
7D
-0.3%
1Y
-27.4%
Dottikon ES Holding
Market Cap: CHF 4.6b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia.
DESN
CHF 331.50
7D
-1.0%
1Y
51.7%
Addex Therapeutics
Market Cap: CHF 6.5m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.056
7D
-0.4%
1Y
-7.0%
Basilea Pharmaceutica
Market Cap: CHF 659.8m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 53.70
7D
2.7%
1Y
29.1%
Idorsia
Market Cap: CHF 981.6m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 3.93
7D
-4.4%
1Y
208.5%
BioVersys
Market Cap: CHF 134.5m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 23.00
7D
-1.7%
1Y
n/a
PolyPeptide Group
Market Cap: CHF 846.2m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 25.65
7D
4.5%
1Y
-12.3%